The Oncology Institute, Inc. TOI Derivative Gain Loss On Derivative Net
Derivative Gain Loss On Derivative Net at other companies
Other financials
Where this comes from
Reported directly by The Oncology Institute, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DerivativeGainLossOnDerivativeNet.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s derivative gain loss on derivative net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s derivative gain loss on derivative net?
- The Oncology Institute, Inc. (TOI) reported derivative gain loss on derivative net of $5M in Q1 2026.
- How has The Oncology Institute, Inc.'s derivative gain loss on derivative net changed year-over-year?
- The Oncology Institute, Inc.'s derivative gain loss on derivative net increased by 251.0% year-over-year, from -$3.31M to $5M.
- What does derivative gain loss on derivative net mean?
- Captures the net impact of changes in the fair value of derivative financial instruments held by the company. This metric reflects the effectiveness of hedging strategies or speculative positions and their subsequent influence on the company's bottom-line profitability.